Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs Care Bare Rx

Alan Meds
Graded #99

Lower grade

vs+3.9000000000000057
Care Bare Rx
Graded #43

Higher grade

The verdict

Care Bare Rx takes it — 75/100 to 71.1/100.

Care Bare Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oral as well as injectable routes for both molecules plus a brand Ozempic lane, bundled with hair, TRT and sexual health.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +4
72
68
Dose & formulationCare Bare Rx +19
75
94
Clinical oversightAlan Meds +8
82
74
Labs & monitoringCare Bare Rx +9
53
62
FulfillmentEven
78
78
Contract termsCare Bare Rx +17
55
72
Alan Meds · left barCare Bare Rx · right bar

The numbers

MetricAlan MedsCare Bare Rx
WeighScore71.1/10075/100
GradeCC
Scorecard rank#99#43
Semaglutide$158/mo (compounded)From $199/mo (shared weight-loss price)
Tirzepatide$295/mo (compounded)From $199/mo (shared weight-loss price)
Coverage46 statesMulti-state
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
Care Bare Rx

Graded #43 · C

Strengths

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard